Citation Impact
Citing Papers
Inhibition of STAT3 with the Generation 2.5 Antisense Oligonucleotide, AZD9150, Decreases Neuroblastoma Tumorigenicity and Increases Chemosensitivity
2016
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
Programmed cell removal by calreticulin in tissue homeostasis and cancer
2018
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
From DNA to proteins via the ribosome: Structural insights into the workings of the translation machinery
2010 StandoutNobel
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
SC3: consensus clustering of single-cell RNA-seq data
2017
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
2012 Standout
Improved semiquantitative Western blot technique with increased quantification range
2009
Neutrophilic leukocytosis in advanced stage polycythemia vera: hematopathologic features and prognostic implications
2015
JAKs and STATs in Immunity, Immunodeficiency, and Cancer
2013
Regulation of chromatin by histone modifications
2011 Standout
Targeting glutamine metabolism in myeloproliferative neoplasms
2015
Drug development from marine natural products
2008 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Translation matters: protein synthesis defects in inherited disease
2007
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
SCENIC: single-cell regulatory network inference and clustering
2017 Standout
Mechanisms and consequences of Jak–STAT signaling in the immune system
2017
Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis
2015
Integrating single-cell transcriptomic data across different conditions, technologies, and species
2018 Standout
Identification and Characterization of 293T Cell-Derived Exosomes by Profiling the Protein, mRNA and MicroRNA Components
2016
Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes
2015 StandoutNobel
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS
2022 StandoutNobel
Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression
2015
Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
2020
The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours
2015
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Expansion of EPOR-negative macrophages besides erythroblasts by elevated EPOR signaling in erythrocytosis mouse models
2017
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Studies on glyphosate-induced carcinogenicity in mouse skin: A proteomic approach
2010
JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin
2009 Nature
Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms
2019
LIF-independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease
2010
Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease
2012
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
Cytokines in Cancer Immunotherapy
2017
5-hydroxymethylcytosine in cancer: significance in diagnosis and therapy
2015
SOCS3 binds specific receptor–JAK complexes to control cytokine signaling by direct kinase inhibition
2013
Epigenetic modifications and human disease
2010 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Molecular mechanisms of mTOR-mediated translational control
2009 Standout
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
2017 Standout
Exosomes
2019 Standout
Identification and transcriptome analysis of erythroblastic island macrophages
2019 StandoutNobel
A Critical Role for Eukaryotic Elongation Factor 1A-1 in Lipotoxic Cell Death
2005
Peptidic degron for IMiD-induced degradation of heterologous proteins
2019 StandoutNobel
JAK2 inhibitors for myeloproliferative neoplasms: what is next?
2017
Oxidative Stress and Diabetic Complications
2010 Standout
TCTP in Development and Cancer
2012 StandoutNobel
New mutations and pathogenesis of myeloproliferative neoplasms
2011
Malaria parasite CelTOS targets the inner leaflet of cell membranes for pore-dependent disruption
2016
Facile bio-synthesis of gold nanoparticles by using extract of Hibiscus sabdariffa and evaluation of its cytotoxicity against U87 glioblastoma cells under hyperglycemic condition
2015 Standout
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
2017 Standout
Tissue-specific contributions of Tmem79 to atopic dermatitis and mast cell-mediated histaminergic itch
2018 StandoutNobel
Elevated Levels of Mast Cells Are Involved in Pruritus Associated with Polycythemia Vera in JAK2V617F Transgenic Mice
2014
Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice
2018
A Knockout Mouse Approach Reveals that TCTP Functions as an Essential Factor for Cell Proliferation and Survival in a Tissue- or Cell Type–specific Manner
2007
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia
2014
Chemical Pesticides and Human Health: The Urgent Need for a New Concept in Agriculture
2016 Standout
Ensemble learning: A survey
2018 Standout
Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value
2010
Structural Basis for the Binding of Didemnins to Human Elongation Factor eEF1A and Rationale for the Potent Antitumor Activity of These Marine Natural Products
2004
Works of Edwin Chen being referenced
Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation
2016
Characterization of Elongation Factor-1A (eEF1A-1) and eEF1A-2/S1 Protein Expression in Normal and wasted Mice
2001
Janus Kinase Deregulation in Leukemia and Lymphoma
2012
Rapid Up-Regulation of Peptide Elongation Factor EF-1α Protein Levels Is an Immediate Early Event during Oxidative Stress-Induced Apoptosis
2000
Structural Analysis of the Synthetic Duffy Binding Protein (DBP) Antigen DEKnull Relevant for Plasmodium vivax Malaria Vaccine Design
2015
Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9
2016
Loss of Ubr1 promotes aneuploidy and accelerates B-cell lymphomagenesis in TLX1/HOX11-transgenic mice
2006
Structural and Functional Basis for Inhibition of Erythrocyte Invasion by Antibodies that Target Plasmodium falciparum EBA-175
2013
ID1 promotes expansion and survival of primary erythroid cells and is a target of JAK2V617F-STAT5 signaling
2009
JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F–positive essential thrombocythemia
2010
Defining the requirements for the pathogenic interaction between mutant calreticulin and MPL in MPN
2017
Mouse models of myeloproliferative neoplasms: JAK of all grades
2011
Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein
2016
Two routes to leukemic transformation after a JAK2 mutation–positive myeloproliferative neoplasm
2009
JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone
2012
Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasms
2014